Cargando…

Evaluation of gut dysbiosis using serum and fecal bile acid profiles

Dysbiosis in the intestinal microflora can affect the gut production of microbial metabolites, and toxic substances can disrupt the barrier function of the intestinal wall, leading to the development of various diseases. Decreased levels of Clostridium subcluster XIVa (XIVa) are associated with the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Monma, Tadakuni, Iwamoto, Junichi, Ueda, Hajime, Tamamushi, Makoto, Kakizaki, Fumio, Konishi, Naoki, Yara, Shoichiro, Miyazaki, Teruo, Hirayama, Takeshi, Ikegami, Tadashi, Honda, Akira
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9791502/ https://www.ncbi.nlm.nih.gov/pubmed/36579096 http://dx.doi.org/10.12998/wjcc.v10.i34.12484

Ejemplares similares

Evaluation of the Risk of Clostridium difficile Infection Using a Serum Bile Acid Profile
por: Monma, Tadakuni, et al.
Publicado: (2022)

Western Diet Changes Gut Microbiota and Ameliorates Liver Injury in a Mouse Model with Human‐Like Bile Acid Composition
por: Iwamoto, Junichi, et al.
Publicado: (2021)

Effects of the Concomitant Use of Low-dose Clarithromycin with an Anti-TNFα Antibody in a Patient with Intestinal Behçet Disease
por: Iwamoto, Junichi, et al.
Publicado: (2017)

Simultaneous quantification of salivary 3-hydroxybutyrate, 3-hydroxyisobutyrate, 3-hydroxy-3-methylbutyrate, and 2-hydroxybutyrate as possible markers of amino acid and fatty acid catabolic pathways by LC–ESI–MS/MS
por: Miyazaki, Teruo, et al.
Publicado: (2015)

Sex-, age-, and organ-dependent improvement of bile acid hydrophobicity by ursodeoxycholic acid treatment: A study using a mouse model with human-like bile acid composition
por: Ueda, Hajime, et al.
Publicado: (2022)

Upregulation of Taurine Biosynthesis and Bile Acid Conjugation with Taurine through FXR in a Mouse Model with Human-like Bile Acid Composition
por: Miyazaki, Teruo, et al.
Publicado: (2023)

The comparison of the intensity of human intestinal spirochetes between Brachyspira pilosicoli and Brachyspira aalborgi infections
por: Iwamoto, Junichi, et al.
Publicado: (2019)

Problems with the concept of gut microbiota dysbiosis
por: Brüssow, Harald
Publicado: (2019)

Differences in the Serum 4β-hydroxycholesterol Levels of Patients with Chronic Hepatitis C Virus (HCV) Infection: A Possible Impact on the Efficacy and Safety of Interferon (IFN)-free Treatment
por: Hirayama, Takeshi, et al.
Publicado: (2017)

Impaired bile acid metabolism with defectives of mitochondrial-tRNA taurine modification and bile acid taurine conjugation in the taurine depleted cats
por: Miyazaki, Teruo, et al.
Publicado: (2020)

Bile acids as drivers and biomarkers of hepatocellular carcinoma
por: Colosimo, Santo, et al.
Publicado: (2022)

Determining Gut Microbial Dysbiosis: a Review of Applied Indexes for Assessment of Intestinal Microbiota Imbalances
por: Wei, Shaodong, et al.
Publicado: (2021)

Role of exercise in preventing and restoring gut dysbiosis in patients with inflammatory bowel diseases: A review
por: Koutouratsas, Tilemachos, et al.
Publicado: (2021)

Serum carnitine as an independent biomarker of malnutrition in patients with impaired oral intake
por: Iwamoto, Junichi, et al.
Publicado: (2014)

Biliary atresia and congenital disorders of the extrahepatic bile ducts
por: Islek, Ali, et al.
Publicado: (2022)

Secondary bile acids and the biliary epithelia: The good and the bad
por: Lenci, Ilaria, et al.
Publicado: (2023)

Comprehensive review on small common bile duct stones
por: Masuda, Sakue, et al.
Publicado: (2023)

Role of bile acids in liver diseases mediated by the gut microbiome
por: Shao, Jun-Wei, et al.
Publicado: (2021)

Impact of Primary and Secondary Bile Acids on Clostridioides Difficile Infection
por: Łukawska, Agata, et al.
Publicado: (2022)

Pitfalls and promises of bile duct alternatives: A narrative review
por: Miyazawa, Mitsuo, et al.
Publicado: (2022)

Current management of concomitant cholelithiasis and common bile duct stones
por: Pavlidis, Efstathios T, et al.
Publicado: (2023)

Update on clinical and research application of fecal biomarkers for gastrointestinal diseases
por: Siddiqui, Imran, et al.
Publicado: (2017)

Fecal microbial transplant for the treatment of pediatric inflammatory bowel disease
por: Wang, Alice Yuxin, et al.
Publicado: (2016)

Gut microbiome dysbiosis in the setting of solid organ transplantation: What we have gleaned from human and animal studies
por: Sharma, Aparna, et al.
Publicado: (2022)

Current status of diagnosis and therapy for intraductal papillary neoplasm of the bile duct
por: Sakai, Yuji, et al.
Publicado: (2021)

Intraductal papillary neoplasm of the bile duct: The new frontier of biliary pathology
por: Mocchegiani, Federico, et al.
Publicado: (2023)

Immunological mechanisms of fecal microbiota transplantation in recurrent Clostridioides difficile infection
por: Soveral, Lucas F, et al.
Publicado: (2022)

Radiation therapy for extrahepatic bile duct cancer: Current evidences and future perspectives
por: Koo, Taeryool, et al.
Publicado: (2019)

Innovation of endoscopic management in difficult common bile duct stone in the era of laparoscopic surgery
por: Lesmana, Cosmas Rinaldi Adithya, et al.
Publicado: (2021)

Remaining issues of recommended management in current guidelines for asymptomatic common bile duct stones
por: Saito, Hirokazu, et al.
Publicado: (2021)

Balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma
por: Hatanaka, Takeshi, et al.
Publicado: (2018)

Inflammatory myofibroblastic tumor of the distal common bile duct: Literature review with focus on pathological examination
por: Cordier, Fleur, et al.
Publicado: (2023)

Laparoscopic common bile duct exploration to treat choledocholithiasis in situs inversus patients: A technical review
por: Chiu, Bo-Ya, et al.
Publicado: (2023)

Bile Acids, Gut Microbes, and the Neighborhood Food Environment—a Potential Driver of Colorectal Cancer Health Disparities
por: Wolf, Patricia G., et al.
Publicado: (2022)

Human-specific dual regulations of FXR-activation for reduction of fatty liver using in vitro cell culture model
por: Miyazaki, Teruo, et al.
Publicado: (2019)

Mechanisms underlying (18)F-fluorodeoxyglucose accumulation in colorectal cancer
por: Kawada, Kenji, et al.
Publicado: (2016)

Mechanisms of gastrointestinal barrier dysfunction in COVID-19 patients
por: Xue, Weijie, et al.
Publicado: (2023)

Longitudinal assessment of microbial dysbiosis, fecal unconjugated bile acid concentrations, and disease activity in dogs with steroid‐responsive chronic inflammatory enteropathy
por: Guard, Blake C., et al.
Publicado: (2019)

Impact of Helicobacter pylori infection on gut microbiota
por: Iino, Chikara, et al.
Publicado: (2021)

Assessment of physical stress during the perioperative period of endoscopic submucosal dissection
por: Chinda, Daisuke, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_iie4kqg3hpurs55lqo9m4jsmg1